ARVINAS, INC.
ARVN
9 insider filings · Latest: Mar 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Mar 20 12:01 AM | Berkowitz NoahChief Medical Officer | Sale | 6,435 | $11.10 | $71.4K | 202,503(D) | View → |
| Mar 6, 2026 | Mar 9 8:05 PM | Briggs MorrisonDirector | Purchase | 20,000 | $13.40 | $268.1K | 96,021(D) | View → |
| Feb 27, 2026 | Mar 3 1:57 AM | John G HoustonDirector | Sale | 35,297 | $13.21 | $466.2K | 1,122,183(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Mar 3 2:01 AM | David K LoomisVP, Chief Accounting Officer | Grant/Award | 18,504 | $13.38 | 18,504(D) | View → |
| Feb 26, 2026 | Mar 3 2:00 AM | Angela M CacaceChief Scientific Officer | Grant/Award | 67,000 | $13.38 | 67,000(D) | View → |
| Feb 26, 2026 | Mar 3 1:59 AM | Berkowitz NoahChief Medical Officer | Grant/Award | 67,000 | $13.38 | 67,000(D) | View → |
| Feb 26, 2026 | Mar 3 1:58 AM | Andrew SaikChief Financial Officer | Grant/Award | 67,000 | $13.38 | 67,000(D) | View → |
| Feb 26, 2026 | Mar 3 1:58 AM | Randy TeelDirector, President and CEO | Grant/Award | 218,691 | $13.38 | 218,691(D) | View → |